ClearView Wealth Ltd (ASX: CVW) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ClearView Wealth Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ClearView Wealth Ltd (ASX: CVW)
Latest News
Small Cap Shares
Morgans names 3 small cap ASX shares to buy
Share Fallers
Why Clearview, NAB, Resolute Mining, and Westpac shares are dropping today
Dividend Investing
Brokers say these ASX dividend stocks are buys
Dividend Investing
3 high-yield ASX dividend stocks named as buys
Dividend Investing
Buy these ASX dividend stocks for 4% to 7% yields
Dividend Investing
2 dirt cheap ASX dividend stocks to buy now
Dividend Investing
Forget the big four banks, these ASX dividend shares offer ~7% yields
Dividend Investing
These buy-rated ASX dividend shares offer 6% yields
Dividend Investing
Buy these ASX dividend shares for a passive income boost
Dividend Investing
These ASX dividend stocks offer 4% to 7% yields
Dividend Investing
3 high-yield ASX dividend shares that are great buys right now
Dividend Investing
Forget term deposits and buy these ASX dividend shares
Frequently Asked Questions
-
Yes, ClearView Wealth has historically paid one fully franked shareholder dividend a year
-
ClearView generally pays its shareholder dividend each September.
-
ClearView Wealth Ltd listed on the ASX on 11 December 2003.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 04 Sep 2024 | $0.0170 | 100.00% | Final | 20 Sep 2024 |
| 07 Mar 2024 | $0.0150 | 100.00% | Interim | 23 Mar 2024 |
| 06 Sep 2023 | $0.0300 | 100.00% | Final | 22 Sep 2023 |
| 07 Sep 2022 | $0.0200 | 100.00% | Final | 23 Sep 2022 |
| 08 Sep 2021 | $0.0100 | 100.00% | Final | 24 Sep 2021 |
| 11 Sep 2018 | $0.0300 | 100.00% | Final | 28 Sep 2018 |
| 12 Sep 2017 | $0.0000 | 100.00% | Final | 29 Sep 2017 |
| 15 Sep 2016 | $0.0250 | 100.00% | Final | 30 Sep 2016 |
| 02 Sep 2014 | $0.0200 | 100.00% | Final | 17 Sep 2014 |
| 24 Sep 2013 | $0.0180 | 100.00% | Final | 08 Oct 2013 |
| 05 Mar 2008 | $0.0400 | 100.00% | Interim | 28 Mar 2008 |
| 17 Sep 2007 | $0.0400 | 100.00% | Final | 05 Oct 2007 |
| 05 Mar 2007 | $0.0400 | 0.00% | Interim | 23 Mar 2007 |
| 01 Sep 2006 | $0.0300 | 100.00% | Final | 21 Sep 2006 |
| 06 Mar 2006 | $0.0300 | 100.00% | Interim | 23 Mar 2006 |
| 02 Sep 2005 | $0.0200 | 100.00% | Final | 22 Sep 2005 |
CVW ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ClearView Wealth Ltd
ClearView Wealth Ltd (ASX: CVW) is a diversified financial services company offering life insurance, superannuation, and wealth management products and services. The company partners with financial and insurance advisors, with about 4,000 advisors currently selling ClearView products and services.
CVW Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 13 Jan 2026 | $0.57 | $0.01 | 1.79% | 27,230 | $0.57 | $0.58 | $0.56 |
| 12 Jan 2026 | $0.56 | $-0.02 | -3.45% | 216,373 | $0.57 | $0.58 | $0.56 |
| 09 Jan 2026 | $0.58 | $0.02 | 3.54% | 75,971 | $0.57 | $0.58 | $0.57 |
| 08 Jan 2026 | $0.57 | $-0.01 | -1.75% | 186,888 | $0.57 | $0.58 | $0.57 |
| 07 Jan 2026 | $0.57 | $0.01 | 1.80% | 25,932 | $0.56 | $0.57 | $0.56 |
| 06 Jan 2026 | $0.56 | $-0.01 | -1.77% | 117,767 | $0.57 | $0.57 | $0.55 |
| 05 Jan 2026 | $0.57 | $-0.01 | -1.75% | 50,045 | $0.55 | $0.57 | $0.55 |
| 02 Jan 2026 | $0.57 | $0.02 | 3.64% | 50,456 | $0.56 | $0.57 | $0.56 |
| 31 Dec 2025 | $0.55 | $-0.01 | -1.79% | 251,002 | $0.56 | $0.56 | $0.55 |
| 30 Dec 2025 | $0.56 | $-0.01 | -1.75% | 96,550 | $0.55 | $0.57 | $0.55 |
| 29 Dec 2025 | $0.57 | $0.02 | 3.64% | 151,199 | $0.54 | $0.57 | $0.53 |
| 24 Dec 2025 | $0.55 | $0.00 | 0.00% | 8,148 | $0.55 | $0.55 | $0.54 |
| 23 Dec 2025 | $0.55 | $0.01 | 1.83% | 97,927 | $0.55 | $0.55 | $0.54 |
| 22 Dec 2025 | $0.55 | $0.00 | 0.00% | 251,102 | $0.54 | $0.55 | $0.54 |
| 19 Dec 2025 | $0.55 | $0.01 | 1.85% | 2,127,832 | $0.54 | $0.55 | $0.54 |
| 18 Dec 2025 | $0.54 | $0.03 | 5.83% | 171,482 | $0.53 | $0.55 | $0.52 |
| 17 Dec 2025 | $0.52 | $-0.01 | -1.92% | 233,582 | $0.52 | $0.52 | $0.51 |
| 16 Dec 2025 | $0.52 | $-0.02 | -3.74% | 521,900 | $0.54 | $0.54 | $0.52 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 13 Nov 2025 | Nadine Gooderick | Issued | 63,756 | $36,978 |
Issue of securities.
|
| 13 Nov 2025 | Nadine Gooderick | Expiry | 277,777 | $161,110 |
As advised by the company. 2713715 Rights, Lapsed
|
| 13 Nov 2025 | Nadine Gooderick | Issued | 1,780,621 | $1,032,760 |
Issue of securities. 44,94,336 Rights
|
| 06 Nov 2025 | Nadine Gooderick | Issued | 63,756 | $37,616 |
Conversion of securities.
|
| 06 Nov 2025 | Nadine Gooderick | Expiry | 277,777 | $163,888 |
As advised by the company. Lapsed, 2713715 Rights
|
| 06 Nov 2025 | Nadine Gooderick | Issued | 1,780,621 | $1,050,566 |
Issue of securities. 4494336 Rights
|
| 06 Nov 2025 | Nadine Gooderick | Exercise | 63,756 | $37,616 |
Conversion of securities. 4,430,580 Rights
|
| 16 Apr 2025 | Edward Fabrizio | Buy | 25,000 | $11,125 |
On-market trade.
|
| 12 Mar 2025 | Jennifer Lyon | Buy | 41,666 | $19,993 |
On-market trade.
|
| 06 Mar 2025 | Geoffrey Black | Buy | 100,000 | $44,000 |
On-market trade.
|
| 06 Mar 2025 | Nadine Gooderick | Buy | 395,821 | $180,251 |
On-market trade. As per announcement on 10-03-2025
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Gary Zalman Burg | Non-Executive Director | Oct 2012 |
Mr Burg has experience in building life insurance businesses in South Africa and in Australia. He currently serves as a member of the Board Risk and Compliance Committee and the Board Investment Committee.
|
| Mr Michael Thomas Alscher | Non-Executive Director | Apr 2024 |
Mr Alscher is the Managing Partner and founder of Crescent Capital Partners Management Pty Limited. Prior to founding Crescent Capital Partners, he was a consultant at Bain International and the LEK Partnership where he spent considerable time working across banking and insurance clients. He is the current Chairman of Green Leaves Early Learning Centres Pty Ltd and Bremick Pty Ltd. He is also a non executive director of New Zealand Panels Group Limited and Steel Mains Holdings Pty Ltd. He was re appointed to the Board on 24 May 2024, following a period as Alternate Director for Eloise Watson. In addition to his Board appointment, he also serves as a member of the Board Investment Committee.
|
| Ms Linda Scott | Non-Executive Director | Jun 2025 |
Ms Scott is the Chair of CareSuper and the Chair of the charity, Alcohol and Drug Foundation (ADF). She is a Director of the Australian Council of Superannuation Investors (ACSI), a Director of Industry Innovation and Science Australia (IISA), and a member of the Director Nomination Committee of IFM Investors. She is also Chair and Commissioner of the NSW Local Government Grants Commission, and a Director of the Powerhouse, the largest museum group in Australia. She previously served as the elected President of the Australian Local Government Association (ALGA), attending National Cabinet and a wide variety of Ministerial councils. She was the first woman elected as President of Local Government NSW and served as the City of Sydneys Deputy Lord Mayor and as a Councillor for more than a decade. She has also served on a range of other boards and taskforces, including the Commonwealth Governments Regional Banking Taskforce, CSIROs External Advisory Group on Ending Plastic Waste and the NSW Environmental Trust. She currently serves as a member of the Board Risk and Compliance Committee.
|
| Mr Nathanial Jonothan Thomson | Non-Executive Director | Oct 2012 |
Mr Thomson is a partner of Crescent Capital Partners Management Pty Limited, a leading Australian private equity investment firm. He has over 20 years of experience from his prior role at McKinsey & Co. He is the current Chair and non executive director of Cardno Limited, National Dental Care Limited, Clover Insurance and AireSafe International Pty Ltd. He is also a non executive director of Emapta and Greenleaves. He currently serves as an alternate member for Michael Alscher on the Board Investment Committee.
|
| Mr Geoffrey Murray Black | Non-Executive DirectorNon-Executive Chairman | Nov 2019 |
Mr Black has over 30 years of experience in life insurance and wealth management and is currently a director of Platypus Asset Management and was Head of Business Development at RGA Australia. Prior to joining the ClearView Board he held senior executive positions at RGA Australia, TAL Australia and was formerly Managing Director of PrefSure Life and Lumley Life Limited. He was appointed to the Board on 25 November 2019 and appointed as Chair of the Board on 1 July 2020. He is a member of the Risk and Compliance Committee.
|
| Ms Jennifer Lyon | Non-Executive Director | Jul 2020 |
Ms Lyon is an experienced actuary, small business owner and Director. She was a founding owner of recruitment firm SKL Executive and served as a Director until December 2020. She has also formerly held a number of senior and Director positions including non-executive Director and President of the Actuaries Institute of Australia, Managing Director of QED Actuarial, a specialist actuarial recruitment firm, a Director of Hall & Lyon which managed the distribution of actuarial education material, and worked at AMP and Towers Perrin in superannuation and financial services. She is a member and Chair of both the Board Risk and Compliance Committee.
|
| Mr Edward Fabrizio | Non-Executive Director | Jun 2023 |
Mr Fabrizio is an experienced life insurance actuary with over 30 years of experience and has been operating his own actuarial consulting business since 2016. Prior to joining the ClearView Board he was the Managing Director of General Reinsurance Life Australia, a Non Executive Director and Council Member of the Institute of Actuaries of Australia, Director in KPMGs Actuarial practice as well as the Appointed Actuary for various life insurance and reinsurance companies. He is Chair of the Board Investment Committee and a member of the Board Risk and Compliance Committee.
|
| Ms Nadine Gooderick | Chief Executive OfficerManaging Director | Jul 2023 |
Ms Gooderick is a life insurance leader with experience managing international programs and leading large diverse teams across different functions and markets. She spent almost 25 years at RGA Reinsurance, including the last eight years as Chief Operating Officer for Australia and New Zealand from 2011 to 2019. In that role, she had responsibility for the key functions of underwriting, medical and technical services, claims and operations as well as project management. Prior to that, she was Vice President, Asia Pacific Regional Office. At RGA, her career highlights include the startup of several of RGAs International Offices as part of the groups global expansion into Asia and Europe as well as the delivery of a substantial, multiyear transformation program for the management of disability income and TPD insurance claims; and the delivery of an end to end group administration system over two years.
|
| Ms Judilyn Beaumont | Company SecretaryGeneral Counsel | Nov 2019 |
-
|
| Ashutosh Bhalerao | Appointed Actuary |
-
|
|
| Athol Chiert | Chief Financial Officer |
-
|
|
| Michael New | Chief Technology Officer |
-
|
|
| Judilyn Beaumont | Company SecretaryGeneral Counsel |
-
|
|
| Christopher Blaxland Walker | Group Executive Distribution |
-
|
|
| Joanne Faglioni | Group Executive Operations |
-
|
|
| Nick Kulikov | Group Executive Product and Pricing |
-
|
|
| Judilyn Beaumont | Group Executive General Counsel Corporate Chief Risk Officer |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Citicorp Nominees Pty Limited | 172,819,572 | 26.74% |
| Perpetual Corporate Trust Limited <Roc Cvw Co Investment A/C> | 64,215,477 | 9.94% |
| Ccp Trusco 4 Pty Limited <Ccp Designated Tst Iva A/C> | 41,802,002 | 6.47% |
| Ccp Bidco Pty Limited <Ccp Bidco Tst 2 A/C> | 32,406,173 | 5.01% |
| Ccp Trusco 5 Pty Limited <Ccp Designated Tst Ivb A/C> | 29,631,331 | 4.58% |
| Ccp Trusco 1 Pty Limited <Ccp Specific Tst Iva A/C> | 27,296,087 | 4.22% |
| J P Morgan Nominees Australia Pty Limited | 22,923,187 | 3.55% |
| Ccp Trusco 3 Pty Limited <Ccp Specific Tst Ivc A/C> | 15,597,762 | 2.41% |
| Ccp Trusco 2 Pty Limited <Ccp Specific Tst Ivb A/C> | 12,998,136 | 2.01% |
| Wintol Pty Ltd | 10,827,624 | 1.68% |
| Portfolio Services Pty Ltd | 10,304,057 | 1.59% |
| HSBC Custody Nominees (Australia) Limited | 9,226,704 | 1.43% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 8,555,502 | 1.32% |
| Perpetual Trustee Company Ltd <Roc Pif> | 7,716,101 | 1.19% |
| UBS Nominees Pty Ltd | 6,895,624 | 1.07% |
| Tamim Investments Pty Limited <Tamim Tvg Spv1 A/C> | 6,502,030 | 1.01% |
| BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 6,310,740 | 0.98% |
| Wintol Pty Ltd <The Gz Burg Family A/C> | 6,302,827 | 0.98% |
| Manyata Holdings Pty Limited <Swanson Family A/C> | 5,550,000 | 0.86% |
| Abn Amro Clearing Sydney Nominees Pty Ltd <Custodian A/C> | 5,201,786 | 0.80% |